Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for pharmaceutical industry professionals · Friday, March 29, 2024 · 699,733,235 Articles · 3+ Million Readers

Unlocking the Potential of the Heparin Market: Trends, Opportunities, and Challenges

Heparin Market

PORTLAND, OR, UNITED STATES, March 21, 2023 /EINPresswire.com/ -- The heparin market refers to the global market for heparin, a blood-thinning medication that is commonly used in the prevention and treatment of blood clots. Heparin is typically derived from the mucous membranes of animals such as pigs and cows, and it is commonly used in a variety of medical settings, including hospitals, clinics, and home care settings.

The heparin market has experienced steady growth over the past few years, driven by factors such as the increasing prevalence of blood clotting disorders and the growing demand for anticoagulant medications. Additionally, the rising incidence of cardiovascular diseases, such as deep vein thrombosis and pulmonary embolism, has also contributed to the growth of the heparin market.

The heparin market is segmented based on various factors such as type, source, application, and geography. There are two main types of heparin: unfractionated heparin (UFH) and low molecular weight heparin (LMWH), each of which has its own unique characteristics and uses.

Some of the key players in the global heparin market include Baxter International Inc., B. Braun Holding GmbH & Co. KG, Dr. Reddyโ€™s Laboratories Ltd., Fresenius SE & Co KGaA, Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Leo Pharma A/S, Pfizer Inc., Sanofi S.A, Teva Pharmaceuticals, and Viatris Inc.. These companies are engaged in activities such as research and development, strategic collaborations, and mergers and acquisitions to enhance their market position and expand their product portfolios.

Overall, the heparin market is expected to continue growing in the future, driven by factors such as the increasing prevalence of blood clotting disorders, the rising incidence of cardiovascular diseases, and the growing demand for anticoagulant medications. However, the market also faces challenges such as the high cost of heparin therapy and the potential risk of side effects associated with its use.

As per the report published by Allied Market Research, the global Heparin Market was pegged at $6.53 billion in 2020, and is expected to reach $11.01 billion by 2028, growing at a CAGR of 6.6% from 2021 to 2028.

Surge in incidence of venous thromboembolism and cardiovascular disorders, rise in use of heparin in surgical procedures, and increase in geriatric populations drive the growth of the global heparin market. However, side effects associated with heparin and presence of alternative anticoagulants hinder the market growth. On the contrary, availability of synthetic and semi-synthetic heparin mimetics and R&D activities to develop heparin with improved therapeutics are expected to create lucrative opportunities for the market players in the future.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/6551

Covid-19 scenario:

The heparin market witnessed a modest growth during the pandemic due to rise in use of low molecular weight heparin for Covid-19 treatment.
A large number of patients are suffering from Covid-19 which is linked to respiratory disease. The demand for heparin has increased as it helps to control respiratory inflation and acts as a blood thinner.
The global heparin market is segmented on the basis of product, application, distribution channel, and region. Based on product, the low molecular weight heparin segment held the lionโ€™s share in 2020, accounting for more than four-fifths of the market. Moreover, the segment is expected to register the highest CAGR of 6.9% during the forecast period.

On the basis of application, the venous thromboembolism segment dominated in 2020, contributing to more than two-fifths of the market. However, the coronary artery disease segment is expected to manifest the highest CAGR of 7.3% from 2021 to 2028.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/6551

The global heparin market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across Asia-Pacific is projected to portray the highest CAGR of 7.8% during the forecast period. However, the market across Europe held the largest share in 2020, accounting for nearly half of the market.

The global heparin market includes an in-depth analysis of the prime market players such as B. Braun Holding GmbH & Co. KG, Baxter International Inc., Fresenius SE & Co KGaA, Dr. Reddyโ€™s Laboratories Ltd., Leo Pharma A/S, Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Pfizer Inc., Sanofi S.A, Teva Pharmaceuticals, and Viatris Inc.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ: https://www.alliedmarketresearch.com/checkout-final/0f2ee702a5e388e87c21eb8ac777770b

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Trending Reports in Industry:

Osteoarthritis Treatment Market>> https://www.alliedmarketresearch.com/osteoarthritis-treatment-market-A12691

Carbinoxamine Market>> https://www.alliedmarketresearch.com/carbinoxamine-market-A12465

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1-800-792-5285
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release